Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Hypertension 1Hot Flashes 1Diabetes Mellitus 1Depressive Disorder, Major 1Depression 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 3Methylphenidate 2Methods 2Ketamine 2Interviews as Topic 2Early Intervention, Educational 2Yoga 1Water 1Ultraviolet Therapy 1Standard of Care 1Self-Help Groups 1SLI381 1Radiotherapy 1Psychotherapy 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Melatonin 1Meditation 1Health 1Focus Groups 1Fatty Acids, Omega-3 1Exercise Therapy 1Escitalopram 1Educational Status 1Duloxetine Hydrochloride 1Desvenlafaxine Succinate 1Decision Support Techniques 1Culture Media 1Cognitive Behavioral Therapy 1Caregivers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Depression × Desvenlafaxine Succinate × Clear all
NCT01803711 2017-12-27

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

UConn Health

Phase 2/3 Terminated
6 enrolled 4 charts

Cardiovascular Diseases, Depression, Depressive Disorder, Major, Diabetes Mellitus, Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡